Jing, Shan http://orcid.org/0000-0002-5648-111X
Shiba, Sari
Morita, Masafumi
Yasuda, Sanae
Lin, Yang http://orcid.org/0000-0002-3036-3633
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects
https://doi.org/10.1007/s40261-022-01241-8
Funding for this research was provided by:
Eisai Co., Ltd.
Article History
Accepted: 22 December 2022
First Online: 6 February 2023
Declarations
:
: This study was funded by Eisai Co., Ltd.
: Shan Jing and Yang Lin declare that they have no conflicts of interest to disclose. Sari Shiba, Masafumi Morita, and Sanae Yasuda are employees of Eisai Co., Ltd.
: The study protocol and informed consent forms were reviewed and approved by the Institutional Review Board of Beijing Anzhen Hospital, China.
: All participants provided written informed consent before participation in the study and after the study procedures had been fully explained.
: The informed consent form included a disclaimer that data will be anonymized and published.
: The data are not available in a repository but reasonable requests can be directed to the corresponding author at ICP@anzhengcp.com.
: Not applicable.
: Study conception and/or design: SJ, SS, SY. Data acquisition: SJ, YL, MM. Data analysis: SJ, SS, SY. Interpretation of results: SJ, YL, MM, SS, SY. All authors were involved in the review and approval of the manuscript, and in the decision to submit the article for publication. All authors also confirm accountability for the accuracy and integrity of the work.